This country profile provides an overview of Liberia’s progress in reaching those in need of mass NTD treatment based on 2019 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Treatment coverage

Elephantiasis
84%
Blinding trachoma
N/A
Intestinal worms
93%
Bilharzia
89%
River blindness
84%
2.98 million people received treatment in Liberia in 2019 197k people did not receive treatment in Liberia in 2019

Elephantiasis

Treatment coverage increased from 68% in 2018 to 84% in 2019.

People needing treatment
2.96m
People receiving treatment
2.5m

Blinding trachoma

Liberia does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage increased from 76% in 2018 to 93% in 2019.

Pre-sch and school-aged children needing treatment
903k
Pre-school and school-aged children receiving treatment
839k

Bilharzia

Treatment coverage decreased from 97% in 2018 to 89% in 2019.

School-aged children needing treatment
605k
School-aged children receiving treatment
539k

River blindness

Treatment coverage increased from 69% in 2018 to 84% in 2019.

People needing treatment
3.18m
People receiving treatment
2.66m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Liberia.